T Utumi, T Hayashi, N Kobayashi. Treatment with eribulin mesilate could suppress epithelial- mesenchymal transition (EMT) in tumors of patients with metastatic breast cancer - preliminary report of a prospective study. EUROPEAN JOURNAL OF CANCER. 2017